Publications
- Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy2020 | Faculty of Medicine in Hradec Králové
- Highly active relapse / reminent multiple sclerosis and okrelizumab after failure of alemtuzumab treatment2020 | Faculty of Medicine in Hradec Králové
- Induction therapy and multiple sclerosis2019 | Faculty of Medicine in Hradec Králové
- Ocrelizumab, clinical activity and progression - long - term data2019 | Faculty of Medicine in Hradec Králové
- Evalution of multiple sclerosis activity and disability2019 | Faculty of Medicine in Hradec Králové
- Alemtuzumab treatment in multiple slerosis: real clinical experience2019 | Faculty of Medicine in Hradec Králové
- Multiple sclerosis: treatment, monitoring, activity and disability2018 | Faculty of Medicine in Hradec Králové
- Multiple sclerosis: treatment safety2018 | Faculty of Medicine in Hradec Králové
- Diagnostics and differential diagnosis of multiple sclerosis2018 | Faculty of Medicine in Hradec Králové
- Dimethyl fumarate and escalation therapy2017 | Faculty of Medicine in Hradec Králové
Loading network view...
